Imani, A., & Golestani, M. (2012). Cost-utility analysis of disease-modifying drugs in relapsing-remitting multiple sclerosis in Iran. Tehran University of Medical Sciences.
استشهاد بنمط شيكاغوImani, Ali, و Mina Golestani. Cost-utility Analysis of Disease-modifying Drugs in Relapsing-remitting Multiple Sclerosis in Iran. Tehran University of Medical Sciences, 2012.
MLA استشهادImani, Ali, و Mina Golestani. Cost-utility Analysis of Disease-modifying Drugs in Relapsing-remitting Multiple Sclerosis in Iran. Tehran University of Medical Sciences, 2012.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.